On March 9, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On March 8, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA is proposing new tobacco product manufacturing practice requirements for manufacturers of finished and bulk tobacco products, it said in a notice scheduled for publication in the March 10 Federal Register. The proposed regulations, which would include requirements for manufacture, pre-production design validation, packing and storage, would also apply to foreign manufacturers and importers finished and bulk tobacco products, FDA said.
On March 7, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On March 6, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On March 3, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On March 2, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On March 1, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Feb. 28, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA announced March 1 that it's expanding its country-wide import alert on enoki mushrooms to include China, subjecting them to detention without physical examination. The import alert was first issued in July 2022 and applied only to enoki mushrooms from South Korea.